Task: Answer the multiple choice question.
Question: Which drug exhibits a 17.929\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] COc1ccc(OC)c(N(CC(=O)NCc2ccncc2)S(C)(=O)=O)c1
[b] O=C(CCNS(=O)(=O)c1cccc2nsnc12)NC1CCCc2ccccc21
Answer: b. O=C(CCNS(=O)(=O)c1cccc2nsnc12)NC1CCCc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCNS(=O)(=O)c1cccc2nsnc12)NC1CCCc2ccccc21
O=C(CCNS(=O)(=O)c1cccc2nsnc12)NC1CCCc2ccccc21
3-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)propanamide